Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 07, 2023 09:15 ET | Source: IR-Med, Inc.

IR-MED Granted Patent in Israel for its AI-Driven Platform Technology: Non-Invasive Analysis of Subcutaneous Tissue

The Granted patent covers IR-MED’s PressureSafe™ decision support device for the early detection of pressure injuries addressing a healthcare burden that amounts to $26.8 billion in the U.S. annually...
October 04, 2023 16:05 ET | Source: IR-Med, Inc.

IR-MED Appoints Healthcare Executive and Entrepreneur Tzur Di-Cori as Chief Executive Officer

Mr. Di-Cori’s vast healthcare experience includes President of LifeWatch Technologies, a developer of technologies that help physicians detect symptoms before they become major health problems Rosh...
September 26, 2023 09:00 ET | Source: IR-Med, Inc.

IR-MED to Conduct Usability Study with Methodist Healthcare of San Antonio for its PressureSafe Device Which is Slated for U.S. Launch in H1 2024

Study to address the substantial challenge of healthcare inequality in the early detection of pressure injuries in people of dark skin tonesPressureSafe, a skin-color agnostic decision support device,...
September 13, 2023 09:15 ET | Source: IR-Med, Inc.

IR-MED Appoints Richard Serbin, Esq. to its Advisory Board

Served as Chief FDA Counsel for Revlon and Johnson & Johnson, as a Board Member at Johnson & Johnson Development Corporation, that company’s strategic venture capital division, and as patent...
August 21, 2023 09:15 ET | Source: IR-Med, Inc.

IR-MED Chairman & Interim CEO Issues Letter to Shareholders

Rosh Pina, Israel, Aug. 21, 2023 (GLOBE NEWSWIRE) -- IR-MED Inc., (“IR-MED” or the “Company”) (OTCQB:IRME), developer of a noninvasive AI-driven infrared spectrographic analysis technology platform...
July 17, 2023 09:15 ET | Source: IR-Med, Inc.

IR-MED’s AI-Powered Infra-Red Spectrographic Decision Support System PressureSafe Device Demonstrates High Efficacy in Detecting Pressure Injuries with 96% Accuracy: Potential to Set a New Standard of Care

IR-MED to file for FDA approval Q4 2023 with U.S. market launch expected in H1 20242.5 million patients develop pressure injuries and 60,000 die annually as a direct result; $26.8 billion is spent...
June 12, 2023 09:15 ET | Source: IR-Med, Inc.

IR-MED Honors Juneteenth with Commitment to Healthcare Equality: PressureSafe Device Sees Beneath the Skin to Address Inequality in Pressure Injuries

Early detection of pressure injuries can be challenging for minority populations due to the current method of visual inspectionPatients with dark skin tones suffered more than twice as much as those...
June 07, 2023 09:28 ET | Source: IR-Med, Inc.

IR-Med Appoints Dr. Lynn Eschenbacher to its Advisory Board as Company Advances Toward Launch of its PressureSafe Wound Care Device

Innovative executive driving positive outcomes and profitability, Dr. Eschenbacher is focused on addressing healthcare access and equityThrough early, non-invasive detection of pressure injuries,...
May 19, 2023 09:15 ET | Source: IR-Med, Inc.

IR-Med’s PressureSafe Noninvasive Wound Care Device to be Demonstrated at Northwell Health’s 10th Annual Shining the Light on Wound Care Symposium

A 94.7% accuracy in identifying Stage 1 pressure injuries was achieved in a proof-of-concept device upon which PressureSafe is basedCompany to exhibit and demo its “sense the invisible” handheld...
March 14, 2023 09:00 ET | Source: IR-Med, Inc.

IR-Med to present at National Pressure Injury Advisory Panel 2023

The company’s PressureSafe device is being designed to reduce healthcare disparity in pressure injury detection and treatment Rosh Pina, Israel, March 14, 2023 (GLOBE NEWSWIRE) -- “IR-MED” or the...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right